Integrating Global Wisdom with a Blueprint for Scientific Innovation Incubation 2023 World Top-Performing Incubator Forum invites you for a journey together.
SHANGHAI, Dec. 1, 2023 /PRNewswire/ — From December 5th to 6th, 2023…
280Bio doses first patient in Phase I clinical trial of TEB-17231, an oral pan-RAS inhibitor in patients with advanced cancers harboring mutations in KRAS, HRAS, or NRAS
SOUTH SAN FRANCISCO, Calif., Dec. 1, 2023 /PRNewswire/ — 280Bio, Inc., a…